Recombinant human serum albumin (OsrHSA) has emerged as a big innovation in the sphere of biopharmaceuticals, offering promising improvements throughout a variety of health-related and industrial applications. With its structural similarity to Normally derived human serum albumin, OsrHSA offers a safer, much more reputable different for therapeutic